FY2025 · ended Dec 31, 2025 · Revenue $385.79M, -36.0% YoY · Filed Feb 17, 2026
Medifast, Inc. (MED) files with the SEC under industry code 2090, Miscellaneous Food Preparations & Kindred Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $385.8 million and a net loss of $18.7 million. Free cash flow was $1.2 million. As of Sep 30, 2026 it held $172.5 million in cash and investments and $20.7 million in total debt.
Revenue (TTM)
$299.57M
-30.3% vs year-ago TTM
Net income (TTM)
$-40.85M
-16572.6% vs year-ago TTM
Operating cash flow (TTM)
$-26,000
-100.4% vs year-ago TTM
Free cash flow (TTM)
$-3.87M
-698.9% vs year-ago TTM
EPS (TTM)
$-3.69
-16420.3% vs year-ago TTM
Dividend per share
$0.00
Shares outstanding
10.99M
+0.5% vs prior year
Net cash
$151.85M
as of Sep 30, 2026
Operating margin
-11.6%
FY 2026
Company profile
- Industry
- Miscellaneous Food Preparations & Kindred Products (SIC 2090)
- Listed as
- MED (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Baltimore, MD
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 910329
- Former names
- HEALTHRITE INC (until Jan 9, 2001)
Other Miscellaneous Food Preparations & Kindred Products companies
- Mccormick & Co Inc MKC
- Utz Brands, Inc. UTZ
- Coffee Holding Co Inc JVA
- Top Wealth Group Holding Ltd TWG
All 5 Miscellaneous Food Preparations & Kindred Products companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $385.8M | $602.5M | $1.1B | $1.6B | $1.5B |
| Operating income | -$14.2M | $2.9M | $126.4M | $184.8M | $216.2M |
| Net income | -$18.7M | $2.1M | $99.4M | $143.6M | $164.0M |
| Diluted EPS | -$1.70 | $0.19 | $9.10 | $12.73 | $13.89 |
| Operating cash flow | $6.9M | $24.5M | $147.7M | $194.6M | $94.5M |
| Free cash flow | $1.2M | $17.0M | $141.2M | $177.9M | $60.3M |
| Total assets | $248.0M | $284.2M | $309.9M | $316.2M | $398.3M |
| Total liabilities | $49.1M | $74.1M | $108.4M | $161.2M | $195.9M |
| Stockholders' equity | $198.9M | $210.1M | $201.5M | $155.0M | $202.5M |
| Cash and investments | $167.3M | $162.3M | $94.4M | $87.7M | $109.5M |
| Total debt | $10.7M | $16.1M | $22.0M | $26.1M | $32.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 26, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 26, 2026 | Oct 26, 2026 |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 17, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 1, 2026 | May 29, 2026 |
All 1000 Medifast, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.